“…Previously [ 23 ], our research group reported PACs (A- and B-types) and flavonol glycosides as the main components of Apollonias barbujana , Laurus novocanariensis (laurel), Ocotea foetens and Persea indica ( Figure 2 ), the most relevant Lauraceae species of Laurissilva. The anti-diabetic effects of similar plants ( Laurus nobilis , Persea americana and Ocotea bullata ) have been documented before [ 3 , 5 , 13 , 24 , 25 , 26 , 27 , 28 , 29 , 30 ], and similar properties were expected for targeted Lauraceae species. Therefore, this study was designed to evaluate for the first time the in vitro inhibitory effects of four Lauraceae plant extracts ( A. barbujana , L. novocanariensis , O. foetens and P. indica ) on digestive enzymes linked to the carbohydrates (α-amylase, and α-glucosidase) and lipids metabolism (pancreatic lipase), aldose reductase and protein glycation.…”